Intercept Pharmaceuticals, Inc. (ICPT)
(Delayed Data from NSDQ)
$89.92 USD
+1.71 (1.94%)
Updated May 3, 2019 04:00 PM ET
After-Market: $89.98 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
ICPT 89.92 +1.71(1.94%)
Will ICPT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ICPT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ICPT
Will Intercept Pharmaceuticals (ICPT) Report Negative Q3 Earnings? What You Should Know
Madrigal (MDGL) to Raise Capital Via Public Offering of $500M
ICPT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Biotech Stock Roundup: ICPT Up on Buyout Deal, IMVT & PLRX Gain on Study Data
Intercept Pharmaceuticals (ICPT) Surges on Acquisition Deal
Intercept (ICPT) Stock Jumps 79.2%: Will It Continue to Soar?